A survey of public attitudes toward drug company partnerships with nonprofits has found deep skepticism of industry motives.
Among respondents to the Envision Solutions survey, 43% said pharmas fund groups like the American Heart Association and the National Kidney Foundation primarily to boost sales of their medicines.
The survey suggests a hardening of attitudes toward such partnerships. By contrast, only 10% of respondents to a similar question in a PRWeek/Barkley Public Relations poll last year said pharmas partner with nonprofits primarily to boost profits.
Envision Solutions pointed to media coverage of “disease mongering” as a likely factor driving cynicism. The consultancy said the number of reports on that topic increased 775% from 2005 to 2006.
The online survey of 1,062 US adults was conducted by polling firm Kelton Research from April 10-13.